Cargando…
The ubiquitin ligase RNF2 stabilizes ERα and modulates breast cancer progression
Estrogen receptor α (ERα) is the most common clinical marker used for breast cancer prognosis and the classification of breast cancer subtypes. Clinically, patients with estrogen receptor-positive breast cancer can receive endocrine therapy. However, resistance to endocrine therapy has become an urg...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813066/ https://www.ncbi.nlm.nih.gov/pubmed/36271315 http://dx.doi.org/10.1007/s13577-022-00810-5 |